Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 18.00 is 15% above its 1-year average of 15.62, near the high end of its 1-year range (13.24–18.00).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly current ratio; no daily interpolation.
Limited quarterly history available
Current Ratio needs at least three reported quarters before a meaningful chart is shown.
CURRENT RATIO
18.00
CURRENT RATIO AVG TTM
N/A
CURRENT RATIO AVG 3Y
N/A
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+380.07%
vs the sector median at left
Seaport Therapeutics, Inc. Common Stock
Market Cap
$929.83M
Current Ratio
18.00
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$921.06M
Current Ratio
12.56
TTM Avg
15.19
3Y Avg
22.99
5Y Avg
17.56
Market Cap
$953.81M
Current Ratio
16.33
TTM Avg
11.68
3Y Avg
16.13
5Y Avg
16.13
Market Cap
$887.99M
Current Ratio
16.16
TTM Avg
3.88
3Y Avg
3.97
5Y Avg
4.50
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Seaport Therapeutics, Inc. Common Stock (SPTX) | $929.83M | 18.00 | N/A | N/A | N/A |
| Kura Oncology, Inc. (KURA)vs › | $934.79M | 4.73 | 7.76 | 11.59 | 15.68 |
| CeriBell, Inc. (CBLL)vs › | $923.53M | 9.18 | 13.23 | 9.24 | 9.24 |
| MoonLake Immunotherapeutics (MLTX)vs › | $921.06M | 12.56 | 15.19 | 22.99 | 17.56 |
| HealthStream, Inc. (HSTM)vs › | $914.73M | 1.06 | 1.14 | 1.09 | 1.06 |
| Savara Inc. (SVRA)vs › | $952.91M | 10.13 | 12.79 | 15.81 | 14.15 |
| Aktis Oncology, Inc. (AKTS)vs › | $953.81M | 16.33 | 11.68 | 16.13 | 16.13 |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $887.99M | 16.16 | 3.88 | 3.97 | 4.50 |
| Bioventus Inc. (BVS)vs › | $887.50M | 1.69 | 1.50 | 1.36 | 1.44 |
| Pacira BioSciences, Inc. (PCRX)vs › | $973.93M | 5.04 | 3.47 | 3.89 | 3.30 |
Current Ratio
18.00
Quick Ratio
18.00
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 18.00 |
| 2026-03-31 | 13.24 |
